The four sessions of CHILI will cover various aspects relating to the fusion of radiology and nuclear medicine with a special focus on its clinical application and therapy management. The conference will start with high-level speakers in a session dedicated to new developments that are on the horizon for hybrid imaging, such as the great leap for full body PET/CT, how to evolve clinical applications for artificial intelligence in multimodality hybrid imaging as well as the translational potential of novel molecular imaging probes.
The remaining three sessions are dedicated to exploring ways to guide clinical therapy with the use of hybrid imaging in the fields of oncology, infection and inflammation. Each of the lectures will be followed by a discussion and Q&A with the audience.
Please note that the programme is still subject to change.
Faculty
A hot programme needs spicy speakers! Read more about each speaker here.
08:25-10:15
Session 1
New Horizons for Hybrid Imaging
click to show all details +
08:25-08:30 – Introduction to CHILI 4.0 (Clemens Cyran)
08:30-08:55
Total body PET/CT – key benefits and applications
Thomas Beyer, Vienna /AT
08:55-09:20
AI in multimodality hybrid imaging
Irène Buvat, Orsay /FR
09:20-09:45
Novel molecular imaging probes for oncologic imaging and what’s their translational potential
Andrew Scott, Melbourne / AUS
09:45-10:15
Round table discussion:
The prospects of clinical implementation for new modalities, probes and algorithms on the horizon.
10:30-12:15
Session 2
Oncology 1: Hybrid imaging as the standard of care
click to show all details +
10:30-10:50
PET/CT in lymphoma – the standard of clinical care
Marius Mayerhöfer, New York / USA
10:50-11:10
Lung carcinoma – the challenges in staging and therapy monitoring
Helmut Prosch, Vienna / AT
11:10-11:30
Why PET/CT in HNSCC?
Andy Scarsbrook, Leeds / UK
11:30-11:50
Melanoma: imaging-based therapeutic management
Marcus Unterrainer, Munich / DE
11:50-12:15
Q&A with the experts
12:30-13:15
Special session
The role of PET-MRI in Neurological Diseases
&
Biograph Vision Quadra – First Clinical Experiences
Sponsored symposium & discussion
click to show all details +
13:30-15:15
Session 3
Oncology 2: The world beyond FDG
click to show all details +
13:30-13:50
Neuroendocrine tumors: therapeutic magagement with SSR-targeting tracers
Clemens Cyran, Munich / DE
13:50-14:10
Prostate carcinoma: PSMA PET/CT in clinical decision guidance
Harun Ilhan, Munich / DE
14:10-14:30
FAPI PET: the new FDG in solid tumors?
Frederik Giesel, Düsseldorf / DE
14:30-14:50
FET PET/MRI in neuro-oncology
Jiří Ferda, Plzeň /CZ
14:50-15:15
Discussion and Q&A with the experts
15:30-16:00
Special session
Value of contrast enhanced CT in hybrid imaging
Sponsored symposium & discussion
click to show all details +
16:15-18:00
Session 4
Infection and Inflammation
click to show all details +
16:15-16:35
Rheumatological diseases: the role of hybrid imaging
Mona-Elisabeth Revheim, Oslo /NO
16:35-16:55
Prothesis infection – from aortic replacements to endoprothesis
Michel Eisenblätter, Freiburg /DE
16:55-17:15
Specific tracers in imaging of inflammation
José Vercher-Conejero, Barcelona /ES
17:15-17:35
Hybrid imaging in COVID-19: What have we learned?
Manil Subesinghe, London /UK
17:35-18:00
Discussion and Q&A with the experts
Faculty
A hot programme needs spicy speakers!
#myspiceforCHILI
Contribute to CHILI with a short video and win!
Accreditation
CHILI is accredited with 7 CME credits.
